Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review

Papillary Renal Neoplasm with Reverse Polarity (PRNRP) is a rare renal tumor, recently described in 2019 by Al-Obaidy et al. defined by characteristic histology of papillary neoplasm with apically located WHO/ISUP grade 1nuclei and frequent <i>KRAS</i> mutations. Multilocular cystic renal neoplasm of low malignant potential (MC-LMP) is an indolent tumor with a characteristic multicystic appearance with cysts lined by WHO/ISUP nuclear grade1 clear cells and presence of <i>VHL</i> alterations similar to that of clear cell renal cell carcinoma (ccRCC); therefore, considered its variant. Simultaneous occurrence of both these tumor types that are immunophenotypically and genetically distinct within same kidney is extremely rare and this is the first case report to date. Herein, we report a case of a 70-year-old male who was incidentally found to have bilateral renal cysts on imaging follow up for cardiovascular problems. The diagnosis of PRNRP and MC-LMP within the same kidney was made on histology in conjunction with ancillary tests. Awareness of PRNRP and MC-LMP is crucial for accurate diagnosis, as these tumors often resemble some of the aggressive variants of Renal cell carcinoma (RCC), such as Papillary RCC (pRCC) and ccRCC respectively on histology. Ability to correctly identify these indolent tumors is essential for optimal treatment options as they are often amenable to partial nephrectomy. This case underscores the need for further research into the pathogenesis and clinical implications of synchronous renal tumors with distinct immunophenotypes, and genomic profiles within the same kidney.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-08-11
DOI
https://doi.org/10.3389/fonc.2025.1605192
Citations
1
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review

Pichayut Nithagon, Rashmi Samdani, Joeffrey J. Chahine, Lambros Stamatakis
1 citations
Frontiers in Oncology
Renal cell carcinoma treatment
1.52
article

Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review

Pichayut Nithagon, Rashmi Samdani, Joeffrey J. Chahine, Lambros Stamatakis
article en
1 citations

Abstract

Papillary Renal Neoplasm with Reverse Polarity (PRNRP) is a rare renal tumor, recently described in 2019 by Al-Obaidy et al. defined by characteristic histology of papillary neoplasm with apically located WHO/ISUP grade 1nuclei and frequent <i>KRAS</i> mutations. Multilocular cystic renal neoplasm of low malignant potential (MC-LMP) is an indolent tumor with a characteristic multicystic appearance with cysts lined by WHO/ISUP nuclear grade1 clear cells and presence of <i>VHL</i> alterations similar to that of clear cell renal cell carcinoma (ccRCC); therefore, considered its variant. Simultaneous occurrence of both these tumor types that are immunophenotypically and genetically distinct within same kidney is extremely rare and this is the first case report to date. Herein, we report a case of a 70-year-old male who was incidentally found to have bilateral renal cysts on imaging follow up for cardiovascular problems. The diagnosis of PRNRP and MC-LMP within the same kidney was made on histology in conjunction with ancillary tests. Awareness of PRNRP and MC-LMP is crucial for accurate diagnosis, as these tumors often resemble some of the aggressive variants of Renal cell carcinoma (RCC), such as Papillary RCC (pRCC) and ccRCC respectively on histology. Ability to correctly identify these indolent tumors is essential for optimal treatment options as they are often amenable to partial nephrectomy. This case underscores the need for further research into the pathogenesis and clinical implications of synchronous renal tumors with distinct immunophenotypes, and genomic profiles within the same kidney.

Frontiers in OncologyVol. 15
Georgetown University (US), MedStar Georgetown University Hospital (US)
Georgetown University
Good health and well-being
Openalex Percentile: Top 15%
Renal cell carcinoma treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.